Melrose Industries PLC MRO.L
Composite 38/100; the shares have moved about 39% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 30/100 — a moderate mark against it.
Valuation ranks 54/100 — a slight point in its favour. Income ranks 53/100 — a slight point in its favour.
Growth ranks 30/100 — a moderate mark against it. Momentum ranks 30/100 — a moderate mark against it. Quality ranks 32/100 — a moderate mark against it.
What the company does Melrose Industries PLC designs and delivers aerospace components and systems for civil and defence markets, operating through Engines and Airframes segments. It supplies structural components, repair services, and electrical systems to original equipment manufacturers globally.
Key financials Melrose reports gross margins of 26.6%, operating margins of 8.3%, and net margins of 10.3%. ROE is 13.1%, ROA 5.0%, and ROCE 15.0%. Revenue grew 8.3% while EPS surged 180.5%. The company maintains a debt/equity ratio of 0.68 and a current ratio of 0.98.
Stock health The stock shows weak momentum, with a 6-month decline of -23.36% and a 12-month drop of -5.38%. The RSI(14) stands at 54.20, indicating neutral momentum. The Sidereavia score is 58.4, with Valuation at 73.3 and Momentum at 31.1.
Price vs fair value The stock trades at a **discount** of 18.00% to our fair-value estimate and a **discount** of 42.17% to the analyst 12-month target. - Shares fell 3.5% after a £30m exceptional cost outlook tied to the Garden Grove incident (Proactive). - H1 2026 earnings call highlighted Garden Grove impact (GuruFocus.com). - Analyst count of 15.0 supports the 12-month target of 683.53 (MarketBeat).
Looking forward Forward P/E is 12.71 (PEG 0.44), suggesting undemanding valuation. Free cash flow yield is 8.0%, and dividend yield is 1.5% with a payout ratio of 22.1%. Growth and quality scores (80.2 and 54.3) indicate potential upside if operational challenges resolve.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.